Schedule 13G ownership disclosure
ACASTI PHARMA INC
Security class unavailable · CUSIP: 00430K105
Event date: 2018-10-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,650,000
- Percent of class
- 10.5800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-19-014281
- Form type
- SC 13G
- Filer
- Grace Therapeutics, Inc.
- CIK
- CIK 1444192
- Filed
- Jul 19, 2019
- Reporting period
- Oct 23, 2018
- Description
- Schedule 13G beneficial ownership